Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cosmeceutical Pioneer Strivectin’s ‘Anti-Aging Solutions’ Draw Drug Claim Warning

This article was originally published in The Tan Sheet

Executive Summary

FDA cites Strivectin’s Potent Wrinkle Reducing Treatment and TL Advanced Tightening Neck Cream as unapproved drugs based on claims touting elastin-stimulating effects, skin-firming action and other structure/function benefits.

Advertisement

Related Content

StriVectin Revises Ad With ‘Clear And Conspicuous’ Disclosure
StriVectin Revises Ad With ‘Clear And Conspicuous’ Disclosure
FDA Shows Skin Authority Who’s Boss In Warning For Drug Claims
FDA Shows Skin Authority Who’s Boss In Warning For Drug Claims
Regulatory News In Brief: House Microbeads Bill; Oregon Eyes Children’s Cosmetics; More
FDA Remains Focused On Cosmetics Carrying Drug Claims – OCAC Director
FDA Warning To L’Oreal Creates Uncertainty For Anti-Redness, Dark Spot Treatments
Beauty Claims "Blur" Difference From Drugs As Cosmeceutical Market Grows
Catterton Tries Its Luck On "Stretch-Mark Cream Turned Anti-Wrinkle Phenom"
Is StriVectin Better Than Botox? Not Without NDA Approval, FDA Says

Topics

Advertisement
UsernamePublicRestriction

Register

PS107568

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel